PlainRecalls
FDA Drug Low Class III Terminated

Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10

Reported: January 25, 2023 Initiated: November 9, 2022 #D-0161-2023

Product Description

Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10

Reason for Recall

Failed Impurity/Degradation Specifications

Details

Recalling Firm
Lannett Company Inc.
Units Affected
20,040 bottles
Distribution
Nationwide USA
Location
Seymour, IN

Frequently Asked Questions

What product was recalled?
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10. Recalled by Lannett Company Inc.. Units affected: 20,040 bottles.
Why was this product recalled?
Failed Impurity/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2023. Severity: Low. Recall number: D-0161-2023.